Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
salmeterol/fluticasone cipla 25 mikrogram/125 mikrogram/dos inhalationsspray, suspension
cipla europe nv - flutikasonpropionat; salmeterolxinafoat - inhalationsspray, suspension - 25 mikrogram/125 mikrogram/dos - salmeterolxinafoat 36,32 mikrog aktiv substans; flutikasonpropionat 125 mikrog aktiv substans - salmeterol och flutikason
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
salmeterol/fluticasone cipla 25 mikrogram/250 mikrogram/dos inhalationsspray, suspension
cipla europe nv - flutikasonpropionat; salmeterolxinafoat - inhalationsspray, suspension - 25 mikrogram/250 mikrogram/dos - salmeterolxinafoat 36,32 mikrog aktiv substans; flutikasonpropionat 250 mikrog aktiv substans - salmeterol och flutikason
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
novucaeli 25 mikrogram/125 mikrogram/dos inhalationsspray, suspension
2care4 aps - flutikasonpropionat; salmeterolxinafoat - inhalationsspray, suspension - 25 mikrogram/125 mikrogram/dos - salmeterolxinafoat 36,32 mikrog aktiv substans; flutikasonpropionat 125 mikrog aktiv substans
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
salmeterol/fluticasone abacus medicine 25 mikrogram/125 mikrogram/dos inhalationsspray, suspension
abacus medicine a/s - flutikasonpropionat; salmeterolxinafoat - inhalationsspray, suspension - 25 mikrogram/125 mikrogram/dos - flutikasonpropionat 125 mikrog aktiv substans; salmeterolxinafoat 36,32 mikrog aktiv substans
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
salmeterol/fluticasone abacus medicine 25 mikrogram/250 mikrogram/dos inhalationsspray, suspension
abacus medicine a/s - flutikasonpropionat; salmeterolxinafoat - inhalationsspray, suspension - 25 mikrogram/250 mikrogram/dos - salmeterolxinafoat 36,32 mikrog aktiv substans; flutikasonpropionat 250 mikrog aktiv substans
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
novucaeli 25 mikrogram/250 mikrogram/dos inhalationsspray, suspension
2care4 aps - flutikasonpropionat; salmeterolxinafoat - inhalationsspray, suspension - 25 mikrogram/250 mikrogram/dos - flutikasonpropionat 250 mikrog aktiv substans; salmeterolxinafoat 36,32 mikrog aktiv substans